NUTRIEN LTD (NTR.CA) Fundamental Analysis & Valuation

TSX:NTR • CA67077M1086

101.69 CAD
+1.25 (+1.24%)
Last: Mar 5, 2026, 07:00 PM

This NTR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to NTR. NTR was compared to 29 industry peers in the Chemicals industry. While NTR belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. NTR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. NTR.CA Profitability Analysis

1.1 Basic Checks

  • In the past year NTR was profitable.
  • NTR had a positive operating cash flow in the past year.
  • NTR had positive earnings in each of the past 5 years.
  • NTR had a positive operating cash flow in each of the past 5 years.
NTR.CA Yearly Net Income VS EBIT VS OCF VS FCFNTR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1.2 Ratios

  • NTR has a Return On Assets of 3.49%. This is amongst the best in the industry. NTR outperforms 86.21% of its industry peers.
  • NTR has a Return On Equity of 7.20%. This is amongst the best in the industry. NTR outperforms 82.76% of its industry peers.
  • NTR has a better Return On Invested Capital (5.23%) than 79.31% of its industry peers.
Industry RankSector Rank
ROA 3.49%
ROE 7.2%
ROIC 5.23%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NTR.CA Yearly ROA, ROE, ROICNTR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • NTR has a better Profit Margin (6.79%) than 86.21% of its industry peers.
  • NTR's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 12.63%, NTR is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
  • NTR's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 30.20%, NTR belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
  • NTR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.63%
PM (TTM) 6.79%
GM 30.2%
OM growth 3Y-19.95%
OM growth 5Y12.68%
PM growth 3Y-25.29%
PM growth 5Y30.88%
GM growth 3Y-6.77%
GM growth 5Y4.73%
NTR.CA Yearly Profit, Operating, Gross MarginsNTR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

4

2. NTR.CA Health Analysis

2.1 Basic Checks

  • NTR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • NTR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NTR.CA Yearly Shares OutstandingNTR.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
NTR.CA Yearly Total Debt VS Total AssetsNTR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

  • An Altman-Z score of 1.96 indicates that NTR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 1.96, NTR is doing good in the industry, outperforming 72.41% of the companies in the same industry.
  • NTR has a debt to FCF ratio of 6.46. This is a slightly negative value and a sign of low solvency as NTR would need 6.46 years to pay back of all of its debts.
  • The Debt to FCF ratio of NTR (6.46) is better than 86.21% of its industry peers.
  • A Debt/Equity ratio of 0.53 indicates that NTR is somewhat dependend on debt financing.
  • NTR has a Debt to Equity ratio of 0.53. This is in the better half of the industry: NTR outperforms 65.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 6.46
Altman-Z 1.96
ROIC/WACC0.37
WACC14.18%
NTR.CA Yearly LT Debt VS Equity VS FCFNTR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • NTR has a Current Ratio of 1.41. This is a normal value and indicates that NTR is financially healthy and should not expect problems in meeting its short term obligations.
  • NTR has a Current ratio of 1.41. This is comparable to the rest of the industry: NTR outperforms 48.28% of its industry peers.
  • A Quick Ratio of 0.89 indicates that NTR may have some problems paying its short term obligations.
  • NTR's Quick ratio of 0.89 is in line compared to the rest of the industry. NTR outperforms 44.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.89
NTR.CA Yearly Current Assets VS Current LiabilitesNTR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. NTR.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.29% over the past year.
  • The Earnings Per Share has been growing by 21.53% on average over the past years. This is a very strong growth
  • Looking at the last year, NTR shows a small growth in Revenue. The Revenue has grown by 3.52% in the last year.
  • The Revenue has been growing slightly by 5.16% on average over the past years.
EPS 1Y (TTM)30.29%
EPS 3Y-29.62%
EPS 5Y21.53%
EPS Q2Q%167.74%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y-10.8%
Revenue growth 5Y5.16%
Sales Q2Q%5.72%

3.2 Future

  • Based on estimates for the next years, NTR will show a decrease in Earnings Per Share. The EPS will decrease by -1.67% on average per year.
  • Based on estimates for the next years, NTR will show a small growth in Revenue. The Revenue will grow by 1.59% on average per year.
EPS Next Y5.08%
EPS Next 2Y-0.14%
EPS Next 3Y1.67%
EPS Next 5Y-1.67%
Revenue Next Year1.44%
Revenue Next 2Y0.42%
Revenue Next 3Y2.48%
Revenue Next 5Y1.59%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NTR.CA Yearly Revenue VS EstimatesNTR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10B 20B 30B
NTR.CA Yearly EPS VS EstimatesNTR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6 8 10

6

4. NTR.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.38, which indicates a correct valuation of NTR.
  • 93.10% of the companies in the same industry are more expensive than NTR, based on the Price/Earnings ratio.
  • NTR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.69.
  • NTR is valuated correctly with a Price/Forward Earnings ratio of 15.58.
  • Based on the Price/Forward Earnings ratio, NTR is valued cheaply inside the industry as 86.21% of the companies are valued more expensively.
  • NTR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.79.
Industry RankSector Rank
PE 16.38
Fwd PE 15.58
NTR.CA Price Earnings VS Forward Price EarningsNTR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NTR is valued cheaply inside the industry as 86.21% of the companies are valued more expensively.
  • 82.76% of the companies in the same industry are more expensive than NTR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.44
EV/EBITDA 8.17
NTR.CA Per share dataNTR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • NTR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.22
PEG (5Y)0.76
EPS Next 2Y-0.14%
EPS Next 3Y1.67%

5

5. NTR.CA Dividend Analysis

5.1 Amount

  • NTR has a Yearly Dividend Yield of 3.11%.
  • NTR's Dividend Yield is a higher than the industry average which is at 2.00.
  • Compared to an average S&P500 Dividend Yield of 1.82, NTR pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.11%

5.2 History

  • The dividend of NTR has a limited annual growth rate of 2.94%.
  • NTR has been paying a dividend for over 5 years, so it has already some track record.
  • NTR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.94%
Div Incr Years6
Div Non Decr Years6
NTR.CA Yearly Dividends per shareNTR.CA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • NTR pays out 58.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The Dividend Rate of NTR has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP58.76%
EPS Next 2Y-0.14%
EPS Next 3Y1.67%
NTR.CA Yearly Income VS Free CF VS DividendNTR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
NTR.CA Dividend Payout.NTR.CA Dividend Payout, showing the Payout Ratio.NTR.CA Dividend Payout.PayoutRetained Earnings

NTR.CA Fundamentals: All Metrics, Ratios and Statistics

NUTRIEN LTD

TSX:NTR (3/5/2026, 7:00:00 PM)

101.69

+1.25 (+1.24%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-18
Earnings (Next)05-06
Inst Owners74.04%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap49.15B
Revenue(TTM)26.89B
Net Income(TTM)1.81B
Analysts72.59
Price Target74.17 (-27.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.11%
Yearly Dividend2.94
Dividend Growth(5Y)2.94%
DP58.76%
Div Incr Years6
Div Non Decr Years6
Ex-Date03-31
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.24%
Min EPS beat(2)0.97%
Max EPS beat(2)9.5%
EPS beat(4)2
Avg EPS beat(4)-16.43%
Min EPS beat(4)-64.42%
Max EPS beat(4)9.5%
EPS beat(8)4
Avg EPS beat(8)-12.86%
EPS beat(12)4
Avg EPS beat(12)-17.39%
EPS beat(16)6
Avg EPS beat(16)-15.21%
Revenue beat(2)1
Avg Revenue beat(2)-1.03%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)1.29%
Revenue beat(4)1
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-6.9%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-3.94%
Revenue beat(12)4
Avg Revenue beat(12)-3.47%
Revenue beat(16)5
Avg Revenue beat(16)-2.55%
PT rev (1m)8.84%
PT rev (3m)10.44%
EPS NQ rev (1m)-3.39%
EPS NQ rev (3m)-5.08%
EPS NY rev (1m)0%
EPS NY rev (3m)3.67%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-0.37%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 16.38
Fwd PE 15.58
P/S 1.36
P/FCF 16.44
P/OCF 8.69
P/B 1.44
P/tB 3.2
EV/EBITDA 8.17
EPS(TTM)6.21
EY6.11%
EPS(NY)6.53
Fwd EY6.42%
FCF(TTM)6.18
FCFY6.08%
OCF(TTM)11.71
OCFY11.51%
SpS75.04
BVpS70.8
TBVpS31.82
PEG (NY)3.22
PEG (5Y)0.76
Graham Number99.46
Profitability
Industry RankSector Rank
ROA 3.49%
ROE 7.2%
ROCE 8.09%
ROIC 5.23%
ROICexc 5.3%
ROICexgc 7.78%
OM 12.63%
PM (TTM) 6.79%
GM 30.2%
FCFM 8.24%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-19.95%
OM growth 5Y12.68%
PM growth 3Y-25.29%
PM growth 5Y30.88%
GM growth 3Y-6.77%
GM growth 5Y4.73%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 6.46
Debt/EBITDA 2.31
Cap/Depr 81.9%
Cap/Sales 7.36%
Interest Coverage 4.41
Cash Conversion 72.18%
Profit Quality 121.28%
Current Ratio 1.41
Quick Ratio 0.89
Altman-Z 1.96
F-Score8
WACC14.18%
ROIC/WACC0.37
Cap/Depr(3y)99.96%
Cap/Depr(5y)102.49%
Cap/Sales(3y)8.31%
Cap/Sales(5y)7.56%
Profit Quality(3y)161.2%
Profit Quality(5y)124.87%
High Growth Momentum
Growth
EPS 1Y (TTM)30.29%
EPS 3Y-29.62%
EPS 5Y21.53%
EPS Q2Q%167.74%
EPS Next Y5.08%
EPS Next 2Y-0.14%
EPS Next 3Y1.67%
EPS Next 5Y-1.67%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y-10.8%
Revenue growth 5Y5.16%
Sales Q2Q%5.72%
Revenue Next Year1.44%
Revenue Next 2Y0.42%
Revenue Next 3Y2.48%
Revenue Next 5Y1.59%
EBIT growth 1Y19.73%
EBIT growth 3Y-28.6%
EBIT growth 5Y18.49%
EBIT Next Year64.61%
EBIT Next 3Y18.23%
EBIT Next 5Y9.68%
FCF growth 1Y-3.86%
FCF growth 3Y-29.33%
FCF growth 5Y2.45%
OCF growth 1Y-8.97%
OCF growth 3Y-20.94%
OCF growth 5Y3.81%

NUTRIEN LTD / NTR.CA FAQ

What is the ChartMill fundamental rating of NUTRIEN LTD (NTR.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to NTR.CA.


Can you provide the valuation status for NUTRIEN LTD?

ChartMill assigns a valuation rating of 6 / 10 to NUTRIEN LTD (NTR.CA). This can be considered as Fairly Valued.


How profitable is NUTRIEN LTD (NTR.CA) stock?

NUTRIEN LTD (NTR.CA) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for NTR stock?

The Price/Earnings (PE) ratio for NUTRIEN LTD (NTR.CA) is 16.38 and the Price/Book (PB) ratio is 1.44.


What is the financial health of NUTRIEN LTD (NTR.CA) stock?

The financial health rating of NUTRIEN LTD (NTR.CA) is 4 / 10.